# Marco Herold

Source: https://onco.cc/people/marco-herold/  
OnCo record `marco-herold` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer biologist who leads the Olivia Newton-John Cancer Research Institute, the research arm of the Olivia Newton-John Cancer Wellness and Research Centre in Melbourne.

## Summary

Professor Marco Herold is Chief Executive Officer of the Olivia Newton-John Cancer Research Institute (ONJCRI), the research institute embedded in the Olivia Newton-John Cancer Wellness and Research Centre, an Austin Health comprehensive cancer service in Heidelberg, Melbourne. He also heads the Blood Cancer and Immunotherapy Laboratory and La Trobe University's School of Cancer Medicine, and joined ONJCRI in 2023 from the Walter and Eliza Hall Institute. His research applies genome wide CRISPR screening to find drug resistance factors and targets that enhance immune therapies.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; immunotherapy; genome-editing
- Role: Chief Executive Officer, Olivia Newton-John Cancer Research Institute
- Specialisms: Blood cancer; Cancer immunotherapy; CRISPR genome editing

## Sources

- Source: ONJCRI our people page: https://www.onjcri.org.au/our-people/

## Connected records

- institutions: [Olivia Newton-John Cancer Wellness and Research Centre](https://onco.cc/institutions/onj-cancer-centre/), [Walter and Eliza Hall Institute of Medical Research](https://onco.cc/institutions/wehi/)
- terms: [Immunotherapy](https://onco.cc/terms/immunotherapy-term/), [Leukaemia (tissue type)](https://onco.cc/terms/leukaemia-type/)

---
JSON: https://onco.cc/api/v1/entities/marco-herold.json